United Kingdom
Vice President, Pulmonary Group Head, Global Clinical Development at Bayer
Pharmaceuticals
Education
Imperial College of Science, Medicine and Technology
Doctorate (Ph.D.), Clinical Pharmacology, Pulmonary Vascular Disease, Pathology
University of Leeds
B.Sc., Human Biology, Physiology, Pharmacology
Experience
Bayer HealthCare June 2014 - Present
Bayer June 2014 - Present
Newcastle University July 2012 - Present
Bayer Healthcare, Pharmaceuticals Division January 2012 - Present
Pfizer February 2010 - October 2011
Pfizer July 2008 - February 2010
Encysive Pharmaceuticals July 2006 - July 2008
The Children's Hospital, Denver September 2004 - June 2006
University of Colorado Denver September 2004 - June 2006
University of Colorado Health Sciences Centre September 2001 - September 2004
Skills
Cell Biology, Cell Culture, Cross-functional Team..., Clinical Trials, Cancer, Clinical Research, Molecular Biology, Market Access, Publication Strategy, CTMS, Neuroscience, R&D, Diabetes, Infectious Diseases, Medical Devices, Clinical Pharmacology, Biochemistry, Technology Transfer, Biopharmaceuticals, Regulatory Submissions, CRO, Science, Commercialization, Cell, FDA Advisory Committee..., Medical Writing, Pharmacovigilance, Dermatology, Drug Development, Regulatory Affairs, GCP, Biomarkers, Medical Affairs, Medicine, Oncology, Cardiology, Life Sciences, Pharmaceutics, Immunology, Therapeutic Areas, Drug Discovery, Pharmacology, Clinical Development, Lifesciences, Pharmaceutical Industry, Pulmonary Hypertension, Healthcare, Biotechnology